Volunteer motivators for participating in HIV vaccine clinical trials in Nairobi, Kenya

Article
Authors
Metrics
Comments
Related Content
Abstract
Introduction
Materials and methods
Results
Discussion
Limitations
Conclusion
Supporting information
Acknowledgments
References
Reader Comments (0)
Media Coverage (0)
Figures
Abstract

Background: 1.5 million Kenyans are living with HIV/AIDS as per 2015 estimates. Though there is a notable decline in new HIV infections, continued effort is still needed to develop an efficacious, accessible and affordable HIV vaccine. HIV vaccine clinical trials bear risks, hence a need to understand volunteer motivators for enrolment, retention and follow-up. Understanding the factors that motivate volunteers to participate in a clinical trial can help to strategize, refine targeting and thus increase enrolment of volunteers in future HIV vaccine clinical trials. The health belief model classifies motivators into social benefits such as ‘advancing research’ and collaboration with science, and personal benefits such as health be...